PPARα deficiency reduces insulin resistance and atherosclerosis in apoE-null mice
Karen Tordjman(Cardiovascular Research Center), Clay F. Semenkovich(Washington University in St. Louis), Carlos Bernal‐Mizrachi(Washington University in St. Louis), Sherry Weng(Cardiovascular Research Center), Fengjuan Zhang(Qingdao University), Feng Chu(Cardiovascular Research Center), Teresa C. Leone(Cardiovascular Institute of the South), Daniel P. Kelly(Washington University in St. Louis), Trey Coleman(Cardiovascular Research Center), Laura Zemany(Beth Israel Deaconess Medical Center)
Cited by 231
Related Papers
Peroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
|Journal of Clinical Investigation|2000|1.3k
PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis
|PLoS Biology|2005|942
A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders
|Proceedings of the National Academy of Sciences|1999|940
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
|Journal of Clinical Investigation|2002|879
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
|Journal of Clinical Investigation|2002|765